glp 1 product How GLP-1 medications are transforming diabetes and weight loss treatment GNC Introduces Semaglutide Support Program:

Purpose of Review: This article summarizes the medical management of obesity with an emphasis on incretin-based therapeutics that target the neuro-hormonal basis of obesity.Recent Findings: Medications that mimic the effect of incretins, a group of peptide hormones released in response to nutrient intake that regulate appetite, result in potent and durable weight loss

GLP-1 injections are designed to minimize discomfort with ultra-fine needles and shallow subcutaneous delivery, making weekly doses manageable for most patients starting weight loss therapy

Newer agents may achieve a normal HbA1c safely and, by analogy with treatments that send cancers or inflammatory diseases into remission, this might also be considered remission

Our unique approach combines these medications with an AI-based app that assists with habit reformation, personalized insights and AI-based tracking

This week, we analysed over 70,000 activities from 305 users taking GLP-1 medication

Explore the findings here: